{"id":2248,"date":"2021-05-13T11:01:34","date_gmt":"2021-05-13T08:01:34","guid":{"rendered":"https:\/\/www.chemi-pharm.com\/?p=2248"},"modified":"2021-05-13T11:04:37","modified_gmt":"2021-05-13T08:04:37","slug":"algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud","status":"publish","type":"post","link":"https:\/\/test2.chemi-pharm.com\/et\/algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud\/","title":{"rendered":"ALGAVAD KOROONAVIIRUSE ANTIKEHADEGA BIOBLOCK NINASPREI KLIINILISED UURINGUD"},"content":{"rendered":"\n<p>T\u00e4nasest algavad koroonaviiruse antikehadega BioBlock ninasprei kliinilised uuringud kahes Tallinna perearstipraksises: Telliskivi perearstikeskuses ning Mustam\u00e4e ja N\u00f5mme perearstikeskuses. Kuigi BioBlock ninasprei on juba m\u00fc\u00fcgil ning laboriuuringud on n\u00e4idanud selles olevate antikehade blokeerivat m\u00f5ju v\u00e4hemalt nelja viirust\u00fcve vastu, pakub kliiniline uuring veelgi p\u00f5hjalikuma ja usaldusv\u00e4\u00e4rsema kinnituse toote t\u00f5hususest.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"640\" height=\"427\" src=\"https:\/\/www.chemi-pharm.com\/wp-content\/uploads\/2021\/05\/AdobeStock_349813861-copy.jpeg\" alt=\"\" class=\"wp-image-2250\" srcset=\"https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/05\/AdobeStock_349813861-copy.jpeg 640w, https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/05\/AdobeStock_349813861-copy-300x200.jpeg 300w, https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/05\/AdobeStock_349813861-copy-600x400.jpeg 600w, https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/05\/AdobeStock_349813861-copy-200x133.jpeg 200w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><figcaption>BioBlock nasal spray clinical trials<\/figcaption><\/figure>\n\n\n\n<p>\u201eKliinilise uuringu k\u00e4igus on v\u00f5imalik teada saada, kui t\u00f5hus on BioBlock inimorganismi kaitsel SARS-CoV-2 viirusesse nakatumise \u00e4rahoidmisel ning kuiv\u00f5rd m\u00f5jutab BioBlocki kasutamine haiguse kulgemist ning raskemate haigusjuhtude \u00e4ra hoidmist. Loodame, et Tallinna ja Harjumaa COVID-19 diagnoosi saanud inimesed tulevad koos peredega uuringuga kaasa.&nbsp; Nende panus on selle Eesti teadust edendava uuringu \u00f5nnestumises k\u00f5ige t\u00e4htsam,\u201c \u00fctles kliinilise uuringu juht, Tartu \u00dclikooli peremeditsiini ja rahvatervishoiu instituudi professor Anneli Uusk\u00fcla.<\/p>\n\n\n\n<p>Uuringus saavad osaleda parasjagu haigust p\u00f5devad inimesed koos pereliikmetega. Kliinilisse uuringusse kaasatakse 342 vabatahtlikku. Uuringu metoodika t\u00f6\u00f6tasid v\u00e4lja Tartu \u00dclikooli teadlased ning selle l\u00e4biviimiseks on heakskiidu andnud Tartu \u00dclikooli inimuuringute eetika komitee.<\/p>\n\n\n\n<p>Ennek\u00f5ike kutsuvad kliinilist uuringut l\u00e4biviivad perearstid osalema oma nimistu koroonadiagnoosi saavaid patsiente koos peredega. V\u00f5imalusel on nad valmis lisama ka patsiente v\u00e4ljastpoolt oma nimistut.<\/p>\n\n\n\n<p>Tallinnas ja selle l\u00e4hi\u00fcmbruses elavad koroonapositiivsed koos pereliikmetega saavad uuringus osalemise soovist m\u00e4rku anda Telliskivi perearstikeskusele aadressil uuring@telliskivi.ee v\u00f5i telefonil 5332 6622, Mustam\u00e4e ja N\u00f5mme perearstikeskusele aadressil mustamaejanommepak@gmail.com ning Mustam\u00e4el telefonil 659 8043 ja N\u00f5mmel 677 0700.<\/p>\n\n\n\n<p>\u201eSoovime koos Icosageni teadlastega SARS-CoV-2 antikehadega ninasprei kaitsev\u00f5imet igak\u00fclgselt uurida. Laboriuuringud ja varased testid on juba n\u00e4idanud, et BioBlock t\u00f6\u00f6tab nii Wuhani, Brasiilia, Suurbritannia kui ka L\u00f5una-Aafrika viiruset\u00fcve vastu. India t\u00fcve osas on testid k\u00e4imas. BioBlock on suurep\u00e4rane n\u00e4ide teadusp\u00f5hisest tootearendusest, mis on suunatud pandeemia l\u00f5petamise teenistusse. Huvi selle toote vastu on nii kodu- kui ka v\u00e4lismaal v\u00e4ga suur. Investeerime uuringutesse, et anda selle toote kasutajatele p\u00f5hjalikumat teavet kaitse t\u00f5hususe kohta,\u201c \u00fctles Chemi-Pharmi juhataja Ruth Oltjer.<\/p>\n\n\n\n<p>\u201ePole kahtlust, et h\u00fcperimmuniseeritud lehma ternespiimast toodetud antikehad inaktiveerivad SARS-CoV-2 viirust, me soovime n\u00fc\u00fcd teada saada, kui efektiivselt suudavad nad seda teha inimese nina limaskestal, kui kasutada ninaspreid,\u201c lisas Icosageni tegevjuht professor Mart Ustav.<\/p>\n\n\n\n<p>BioBlocki tootmist ja m\u00fc\u00fcki lubava otsuse on v\u00e4ljastanud Terviseamet, v\u00f5ttes aluseks Ravimiameti, Terviseameti, P\u00f5llumajandus- ja Toiduameti ning Tarbijakaitse ja Tehnilise J\u00e4relevalve ameti spetsialistidest koosneva piiripealsete toodete ekspertt\u00f6\u00f6r\u00fchma seisukoha. BioBlock ei ole juriidiliselt ravim ega meditsiiniseade, kuid selle tooteinfo ja pakendiinfo on koosk\u00f5lastatud nii Ravimiameti kui ka Terviseametiga.<\/p>\n\n\n\n<p>Bioblock on eestimaine innovatiivne toode, mille kontseptsiooni ja antikehade lahuse t\u00f6\u00f6tasid professor Mart Ustavi juhtimisel v\u00e4lja Icosageni teadlased. BioBlocki toote arendamist ja turule toomist juhtisid Chemi-Pharmi spetsialistid koost\u00f6\u00f6s Tartu \u00dclikooli ja Icosageni teadlastega. Toode on patenteeritud Icosagen Cell Factory O\u00dc, AS Chemi-Pharm, O\u00dc Teadus ja Tegu, Eesti Maa\u00fclikool ja Tartu \u00dclikooli kaasava tehnoloogia konsortsiumi poolt. BioBlock ninaspreid toodab ja turustab Chemi-Pharm AS.<\/p>\n","protected":false},"excerpt":{"rendered":"T\u00e4nasest algavad koroonaviiruse antikehadega BioBlock ninasprei kliinilised uuringud kahes Tallinna perearstipraksises: Telliskivi perearstikeskuses ning Mustam\u00e4e ja N\u00f5mme perearstikeskuses. Kuigi BioBlock ninasprei on juba m\u00fc\u00fcgil ning laboriuuringud on n\u00e4idanud selles olevate antikehade blokeerivat m\u00f5ju v\u00e4hemalt nelja viirust\u00fcve vastu, pakub kliiniline uuring veelgi p\u00f5hjalikuma ja usaldusv\u00e4\u00e4rsema kinnituse toote t\u00f5hususest. \u201eKliinilise uuringu k\u00e4igus on v\u00f5imalik teada saada, kui [&hellip;]","protected":false},"author":2,"featured_media":2250,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_uag_custom_page_level_css":"","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","ngg_post_thumbnail":0,"footnotes":""},"categories":[10],"tags":[],"class_list":["post-2248","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uudised-est"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ALGAVAD KOROONAVIIRUSE ANTIKEHADEGA BIOBLOCK NINASPREI KLIINILISED UURINGUD - Chemi-Pharm<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/test2.chemi-pharm.com\/et\/algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud\/\" \/>\n<meta property=\"og:locale\" content=\"et_EE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ALGAVAD KOROONAVIIRUSE ANTIKEHADEGA BIOBLOCK NINASPREI KLIINILISED UURINGUD - Chemi-Pharm\" \/>\n<meta property=\"og:description\" content=\"T\u00e4nasest algavad koroonaviiruse antikehadega BioBlock ninasprei kliinilised uuringud kahes Tallinna perearstipraksises: Telliskivi perearstikeskuses ning Mustam\u00e4e ja N\u00f5mme perearstikeskuses. Kuigi BioBlock ninasprei on juba m\u00fc\u00fcgil ning laboriuuringud on n\u00e4idanud selles olevate antikehade blokeerivat m\u00f5ju v\u00e4hemalt nelja viirust\u00fcve vastu, pakub kliiniline uuring veelgi p\u00f5hjalikuma ja usaldusv\u00e4\u00e4rsema kinnituse toote t\u00f5hususest. \u201eKliinilise uuringu k\u00e4igus on v\u00f5imalik teada saada, kui [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/test2.chemi-pharm.com\/et\/algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud\/\" \/>\n<meta property=\"og:site_name\" content=\"Chemi-Pharm\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/chemipharmeesti\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-13T08:01:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-05-13T08:04:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/05\/AdobeStock_349813861-copy.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"427\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Triin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud\\\/\"},\"author\":{\"name\":\"Triin\",\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/#\\\/schema\\\/person\\\/1b68d1c5fad653007197c18787077baa\"},\"headline\":\"ALGAVAD KOROONAVIIRUSE ANTIKEHADEGA BIOBLOCK NINASPREI KLIINILISED UURINGUD\",\"datePublished\":\"2021-05-13T08:01:34+00:00\",\"dateModified\":\"2021-05-13T08:04:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud\\\/\"},\"wordCount\":501,\"publisher\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/AdobeStock_349813861-copy.jpeg\",\"articleSection\":[\"Uudised eestikeelsed\"],\"inLanguage\":\"et\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud\\\/\",\"url\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud\\\/\",\"name\":\"ALGAVAD KOROONAVIIRUSE ANTIKEHADEGA BIOBLOCK NINASPREI KLIINILISED UURINGUD - Chemi-Pharm\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/AdobeStock_349813861-copy.jpeg\",\"datePublished\":\"2021-05-13T08:01:34+00:00\",\"dateModified\":\"2021-05-13T08:04:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud\\\/#breadcrumb\"},\"inLanguage\":\"et\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"et\",\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud\\\/#primaryimage\",\"url\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/AdobeStock_349813861-copy.jpeg\",\"contentUrl\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/AdobeStock_349813861-copy.jpeg\",\"width\":640,\"height\":427,\"caption\":\"BioBlock nasal spray clinical trials \\\/AdobeStock\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ALGAVAD KOROONAVIIRUSE ANTIKEHADEGA BIOBLOCK NINASPREI KLIINILISED UURINGUD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/#website\",\"url\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/\",\"name\":\"Chemi-Pharm\",\"description\":\"Chemi-Pharm&#039;i professionaalsed ja k\u00f5rge kvaliteediga desinfektsiooni- ja puhastusvahendid otse tootjalt\",\"publisher\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"et\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/#organization\",\"name\":\"Chemi-Pharm\",\"url\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"et\",\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.chemi-pharm.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Group-17-1.svg\",\"contentUrl\":\"https:\\\/\\\/www.chemi-pharm.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Group-17-1.svg\",\"width\":282,\"height\":27,\"caption\":\"Chemi-Pharm\"},\"image\":{\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/chemipharmeesti\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/test2.chemi-pharm.com\\\/et\\\/#\\\/schema\\\/person\\\/1b68d1c5fad653007197c18787077baa\",\"name\":\"Triin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"et\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8e29bed29280b7c94fe122ff5e2654c664c5f8ba43de76f384ff762482df602d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8e29bed29280b7c94fe122ff5e2654c664c5f8ba43de76f384ff762482df602d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8e29bed29280b7c94fe122ff5e2654c664c5f8ba43de76f384ff762482df602d?s=96&d=mm&r=g\",\"caption\":\"Triin\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ALGAVAD KOROONAVIIRUSE ANTIKEHADEGA BIOBLOCK NINASPREI KLIINILISED UURINGUD - Chemi-Pharm","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/test2.chemi-pharm.com\/et\/algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud\/","og_locale":"et_EE","og_type":"article","og_title":"ALGAVAD KOROONAVIIRUSE ANTIKEHADEGA BIOBLOCK NINASPREI KLIINILISED UURINGUD - Chemi-Pharm","og_description":"T\u00e4nasest algavad koroonaviiruse antikehadega BioBlock ninasprei kliinilised uuringud kahes Tallinna perearstipraksises: Telliskivi perearstikeskuses ning Mustam\u00e4e ja N\u00f5mme perearstikeskuses. Kuigi BioBlock ninasprei on juba m\u00fc\u00fcgil ning laboriuuringud on n\u00e4idanud selles olevate antikehade blokeerivat m\u00f5ju v\u00e4hemalt nelja viirust\u00fcve vastu, pakub kliiniline uuring veelgi p\u00f5hjalikuma ja usaldusv\u00e4\u00e4rsema kinnituse toote t\u00f5hususest. \u201eKliinilise uuringu k\u00e4igus on v\u00f5imalik teada saada, kui [&hellip;]","og_url":"https:\/\/test2.chemi-pharm.com\/et\/algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud\/","og_site_name":"Chemi-Pharm","article_publisher":"https:\/\/www.facebook.com\/chemipharmeesti","article_published_time":"2021-05-13T08:01:34+00:00","article_modified_time":"2021-05-13T08:04:37+00:00","og_image":[{"width":640,"height":427,"url":"https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/05\/AdobeStock_349813861-copy.jpeg","type":"image\/jpeg"}],"author":"Triin","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/test2.chemi-pharm.com\/et\/algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud\/#article","isPartOf":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud\/"},"author":{"name":"Triin","@id":"https:\/\/test2.chemi-pharm.com\/et\/#\/schema\/person\/1b68d1c5fad653007197c18787077baa"},"headline":"ALGAVAD KOROONAVIIRUSE ANTIKEHADEGA BIOBLOCK NINASPREI KLIINILISED UURINGUD","datePublished":"2021-05-13T08:01:34+00:00","dateModified":"2021-05-13T08:04:37+00:00","mainEntityOfPage":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud\/"},"wordCount":501,"publisher":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/#organization"},"image":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud\/#primaryimage"},"thumbnailUrl":"https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/05\/AdobeStock_349813861-copy.jpeg","articleSection":["Uudised eestikeelsed"],"inLanguage":"et"},{"@type":"WebPage","@id":"https:\/\/test2.chemi-pharm.com\/et\/algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud\/","url":"https:\/\/test2.chemi-pharm.com\/et\/algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud\/","name":"ALGAVAD KOROONAVIIRUSE ANTIKEHADEGA BIOBLOCK NINASPREI KLIINILISED UURINGUD - Chemi-Pharm","isPartOf":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/#website"},"primaryImageOfPage":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud\/#primaryimage"},"image":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud\/#primaryimage"},"thumbnailUrl":"https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/05\/AdobeStock_349813861-copy.jpeg","datePublished":"2021-05-13T08:01:34+00:00","dateModified":"2021-05-13T08:04:37+00:00","breadcrumb":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud\/#breadcrumb"},"inLanguage":"et","potentialAction":[{"@type":"ReadAction","target":["https:\/\/test2.chemi-pharm.com\/et\/algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud\/"]}]},{"@type":"ImageObject","inLanguage":"et","@id":"https:\/\/test2.chemi-pharm.com\/et\/algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud\/#primaryimage","url":"https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/05\/AdobeStock_349813861-copy.jpeg","contentUrl":"https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/05\/AdobeStock_349813861-copy.jpeg","width":640,"height":427,"caption":"BioBlock nasal spray clinical trials \/AdobeStock"},{"@type":"BreadcrumbList","@id":"https:\/\/test2.chemi-pharm.com\/et\/algavad-koroonaviiruse-antikehadega-bioblock-ninasprei-kliinilised-uuringud\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/test2.chemi-pharm.com\/et\/"},{"@type":"ListItem","position":2,"name":"ALGAVAD KOROONAVIIRUSE ANTIKEHADEGA BIOBLOCK NINASPREI KLIINILISED UURINGUD"}]},{"@type":"WebSite","@id":"https:\/\/test2.chemi-pharm.com\/et\/#website","url":"https:\/\/test2.chemi-pharm.com\/et\/","name":"Chemi-Pharm","description":"Chemi-Pharm&#039;i professionaalsed ja k\u00f5rge kvaliteediga desinfektsiooni- ja puhastusvahendid otse tootjalt","publisher":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/test2.chemi-pharm.com\/et\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"et"},{"@type":"Organization","@id":"https:\/\/test2.chemi-pharm.com\/et\/#organization","name":"Chemi-Pharm","url":"https:\/\/test2.chemi-pharm.com\/et\/","logo":{"@type":"ImageObject","inLanguage":"et","@id":"https:\/\/test2.chemi-pharm.com\/et\/#\/schema\/logo\/image\/","url":"https:\/\/www.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Group-17-1.svg","contentUrl":"https:\/\/www.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Group-17-1.svg","width":282,"height":27,"caption":"Chemi-Pharm"},"image":{"@id":"https:\/\/test2.chemi-pharm.com\/et\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/chemipharmeesti"]},{"@type":"Person","@id":"https:\/\/test2.chemi-pharm.com\/et\/#\/schema\/person\/1b68d1c5fad653007197c18787077baa","name":"Triin","image":{"@type":"ImageObject","inLanguage":"et","@id":"https:\/\/secure.gravatar.com\/avatar\/8e29bed29280b7c94fe122ff5e2654c664c5f8ba43de76f384ff762482df602d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8e29bed29280b7c94fe122ff5e2654c664c5f8ba43de76f384ff762482df602d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8e29bed29280b7c94fe122ff5e2654c664c5f8ba43de76f384ff762482df602d?s=96&d=mm&r=g","caption":"Triin"}}]}},"author_meta":{"display_name":"Triin","author_link":"https:\/\/test2.chemi-pharm.com\/et\/author\/triin-ch\/"},"featured_img":"https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/05\/AdobeStock_349813861-copy-300x200.jpeg","uagb_featured_image_src":{"full":["https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/05\/AdobeStock_349813861-copy.jpeg",640,427,false],"thumbnail":["https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/05\/AdobeStock_349813861-copy-150x150.jpeg",150,150,true],"medium":["https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/05\/AdobeStock_349813861-copy-300x200.jpeg",300,200,true],"medium_large":["https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/05\/AdobeStock_349813861-copy.jpeg",640,427,false],"large":["https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/05\/AdobeStock_349813861-copy.jpeg",640,427,false],"1536x1536":["https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/05\/AdobeStock_349813861-copy.jpeg",640,427,false],"2048x2048":["https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/05\/AdobeStock_349813861-copy.jpeg",640,427,false],"news_thumb":["https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/05\/AdobeStock_349813861-copy-600x400.jpeg",600,400,true],"custom_thumb":["https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2021\/05\/AdobeStock_349813861-copy-200x133.jpeg",200,133,true]},"uagb_author_info":{"display_name":"Triin","author_link":"https:\/\/test2.chemi-pharm.com\/et\/author\/triin-ch\/"},"uagb_comment_info":0,"uagb_excerpt":"T\u00e4nasest algavad koroonaviiruse antikehadega BioBlock ninasprei kliinilised uuringud kahes Tallinna perearstipraksises: Telliskivi perearstikeskuses ning Mustam\u00e4e ja N\u00f5mme perearstikeskuses. Kuigi BioBlock ninasprei on juba m\u00fc\u00fcgil ning laboriuuringud on n\u00e4idanud selles olevate antikehade blokeerivat m\u00f5ju v\u00e4hemalt nelja viirust\u00fcve vastu, pakub kliiniline uuring veelgi p\u00f5hjalikuma ja usaldusv\u00e4\u00e4rsema kinnituse toote t\u00f5hususest. \u201eKliinilise uuringu k\u00e4igus on v\u00f5imalik teada saada, kui&hellip;","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/test2.chemi-pharm.com\/et\/category\/uudised-est\/\" class=\"advgb-post-tax-term\">Uudised eestikeelsed<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Uudised eestikeelsed<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 5 aastat ago","modified":"Updated 5 aastat ago"},"absolute_dates":{"created":"Posted on 13. mai 2021","modified":"Updated on 13. mai 2021"},"absolute_dates_time":{"created":"Posted on 13. mai 2021 11:01","modified":"Updated on 13. mai 2021 11:04"},"featured_img_caption":"BioBlock nasal spray clinical trials \/AdobeStock","series_order":"","_links":{"self":[{"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/posts\/2248","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/comments?post=2248"}],"version-history":[{"count":3,"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/posts\/2248\/revisions"}],"predecessor-version":[{"id":2254,"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/posts\/2248\/revisions\/2254"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/media\/2250"}],"wp:attachment":[{"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/media?parent=2248"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/categories?post=2248"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/test2.chemi-pharm.com\/et\/wp-json\/wp\/v2\/tags?post=2248"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}